Yayın:
Prognostic Significance of Tumor Tissue NeuGcGM3 Ganglioside Expression in Patients Receiving Racotumomab Immunotherapy

Sadeleştirilmiş öğe sayfası
dc.contributor.authorÜskent, Necdet
dc.contributor.authorAydıncer, Cenk
dc.contributor.authorBaloğlu, Hüseyi̇n
dc.contributor.authorMetin Özkan
dc.contributor.authorMehmet Teomete
dc.contributor.authorHüseyi̇n Baloğlu
dc.contributor.authorCenk Aydıncer
dc.contributor.authorHale Yergok
dc.contributor.authorEnder Doğan
dc.contributor.authorBarkın Berk
dc.contributor.authorAziz Yazar
dc.contributor.orcid0000-0003-2739-7362
dc.contributor.orcid0000-0003-2143-5268
dc.contributor.orcid0000-0002-8837-0756
dc.contributor.orcid0000-0003-0359-0504
dc.contributor.orcid0000-0001-8434-393X
dc.contributor.orcid0000-0001-6047-2796
dc.date.accessioned2025-11-13T10:59:18Z
dc.date.issued2020-06-29
dc.identifier.doihttps://doi.org/10.1155/2020/1360431
dc.identifier.endpage7
dc.identifier.issn1687-8450
dc.identifier.openalexW3037224556
dc.identifier.startpage1
dc.identifier.urihttps://hdl.handle.net/11421/5875
dc.identifier.urihttps://doi.org/10.1155/2020/1360431
dc.identifier.volume2020
dc.language.isoen
dc.relation.ispartofJournal of Oncology
dc.rightsopenAccess
dc.subjectMedicine
dc.subjectImmunohistochemistry
dc.subjectStatistical significance
dc.subjectClinical significance
dc.subjectImmunotherapy
dc.subjectGanglioside
dc.subjectBiomarker
dc.subjectInternal medicine
dc.subjectCorrelation
dc.subjectOncology
dc.subjectPathology
dc.subjectCancer
dc.subjectBiology
dc.subject.sdg3
dc.titlePrognostic Significance of Tumor Tissue NeuGcGM3 Ganglioside Expression in Patients Receiving Racotumomab Immunotherapy
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5064757657
local.authorid.openalexA5028967077
local.authorid.openalexA5108775494

Dosyalar

Koleksiyonlar

Publications